APA (7th ed.) Citation

M, V., L, H., M, V., M, v. H., JAF, P., G, A., . . . MA, V. (2023). Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. Neuro-oncology advances, 5(1), vdad152. https://doi.org/10.1093/noajnl/vdad152

Chicago Style (17th ed.) Citation

M, Verduin, et al. "Patient-derived Glioblastoma Organoids Reflect Tumor Heterogeneity and Treatment Sensitivity." Neuro-oncology Advances 5, no. 1 (2023): vdad152. https://doi.org/10.1093/noajnl/vdad152.

MLA (9th ed.) Citation

M, Verduin, et al. "Patient-derived Glioblastoma Organoids Reflect Tumor Heterogeneity and Treatment Sensitivity." Neuro-oncology Advances, vol. 5, no. 1, 2023, p. vdad152, https://doi.org/10.1093/noajnl/vdad152.